Search

Your search keyword '"Ponsioen, Cyriel Y."' showing total 174 results

Search Constraints

Start Over You searched for: Author "Ponsioen, Cyriel Y." Remove constraint Author: "Ponsioen, Cyriel Y." Database Unpaywall Remove constraint Database: Unpaywall
174 results on '"Ponsioen, Cyriel Y."'

Search Results

1. THU-138 The male-to-female ratio among patients with primary biliary cholangitis depends on age

2. Incidence and prevalence of primary biliary cholangitis in the Netherlands – a nationwide cohort study

3. THU-100 Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis

4. THU-120-YI The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort

6. Recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy: incidence and risk factors

8. Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease

9. Per-oral cholangioscopy in patients with primary sclerosing cholangitis: a 12-month follow-up study

13. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial

14. LONG-TERM EFFICACY OF METAL VERSUS PLASTIC STENTS IN INOPERABLE PERIHILAR CHOLANGIOCARCINOMA; A MULTICENTER RETROSPECTIVE PROPENSITY SCORE MATCHED COMPARISON

16. LONG-TERM EFFICACY OF METAL VERSUS PLASTIC STENTS IN INOPERABLE PERIHILAR CHOLANGIOCARCINOMA; A MULTICENTER RETROSPECTIVE PROPENSITY SCORE MATCHED COMPARISON

17. Endobiliary radiofrequency ablation combined with metal stents for malignant biliary obstruction due to perihilar cholangiocarcinoma (RACCOON-p): a prospective pilot study

18. Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison

19. Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

20. Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry

21. Challenges and costs of donor screening for fecal microbiota transplantations

22. Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis

23. Drivers and determinants of strain dynamics following fecal microbiota transplantation

24. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

26. Su1357: PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH LONG-TERM OBETICHOLIC ACID IN A TRIAL-SETTING DEMONSTRATE BETTER EVENT-FREE SURVIVAL OUTCOMES THAN EXTERNAL CONTROLS FROM THE GLOBAL PBC AND UK-PBC STUDY GROUPS

27. Mo1562: SWITCHING INTRAVENOUS VEDOLIZUMAB MAINTENANCE TREATMENT TO SUBCUTANEOUS VEDOLIZUMAB TREATMENT FOR INFLAMMATORY BOWEL DISEASE

30. Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis

31. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis

32. Long-Term Outcomes of Crohn's Perianal Fistulas Treatment: Short-Term Anti-Tnf Therapy with Surgical Closure Versus Anti-TNF Therapy (PISA-II) - A Patient Preference RCT

33. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

34. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process

35. Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity

36. Predictors of Jaundice Resolution and Survival After Endoscopic Treatment of Primary Sclerosing Cholangitis

40. Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study

41. Sa456 DECREASE IN BOWEL WALL THICKNESS AT INTESTINAL ULTRASOUND ACCURATELY DETECTS EARLY ENDOSCOPIC REMISSION AND TREATMENT RESPONSE IN ULCERATIVE COLITIS PATIENTS ON TOFACITINIB: A LONGITUDINAL PROSPECTIVE COHORT STUDY

42. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients

43. Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study

46. Simplified care-pathway selection for nonspecialist practice

48. Impaired Quality of Working Life in Inflammatory Bowel Disease Patients

49. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

50. Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Catalog

Books, media, physical & digital resources